Dose reconstruction of Di(2-ethylhexyl) phthalate using a simple pharmacokinetic model

Environmental Health Perspectives

Volumn 120, Issue 12, 2012, Pages 1705-1710

  Lorber, Matthew ^a   Calafat, Antonia M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

DEHP; Dose reconstruction; Pharmacokinetic model; Phthalate exposure

Indexed keywords

CREATININE; MONO(2 ETHYL 5 CARBOXYPENTYL) PHTHALATE; MONO(2 ETHYL 5 HYDROXYHEXYL) PHTHALATE; MONO(2 ETHYL 5 OXOHEXYL) PHTHALATE; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS (2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEVERAGE; BIOLOGICAL MONITORING; DRUG EXPOSURE; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; MALE; MICTURITION; PRIORITY JOURNAL; URINALYSIS;

ADULT; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PLASTICIZERS; YOUNG ADULT;

EID: 84870549362     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205182     Document Type: Article

References (21)

1. Anderson WAC, Castle L, Hird S, Jeffrey J, Scotter MJ. 2011. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate. Food Chem Toxicol 49:2022-2029.
2. Barr DB, Silva MF, Kato K, Reidy JA, Malek NA, Hurtz D, et al. 2003. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect 111:1148-1151.
3. Clark KE, David RM, Guinn R, Kramarz KW, Lampie MA, Staples CA. 2011. Modeling human exposure to phthalate esters: a comparison of indirect and biomonitoring estimation methods. Hum Ecol Risk Assess 17:923-965.
4. David RM, McKee RH, Butala JH, Barter RA, Kayser M. 2001. Esters of aromatic mono-, di-, and tricarboxylic acids, aromatic diacids, and di-, tri-, or polyalcohols. In: Patty's Toxicology, Vol 6 (Bingham E, Cohrssen B, Powell CH, eds). 5th ed. New York:John Wiley and Sons, 635-932.
5. Fromme H, Gruber L, Schlummer M, Wolz G, Bohmer S, Angerer J, et al. 2007. Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ Int 33:1012-1020.
6. Fujimaki K, Yoshinaga J, Watanabe C, Serizawwa S, Shiraishi H, Mizumoto Y. 2006. Estimation of intake level of di (2-ethyhexyl) phthalate (DEHP) in Japanese pregnant women based on measurement of concentrations of three urinary metabolites [in Japanese]. Nippon Eiseigaku Zasshi 61:340-347.
7. Huang PC, Kuo PL, Lee CC. 2006. The association between urinary monoester phthalates and thyroid hormone in pregnant women [Abstract]. Epidemiology 17(6):S195.
8. Kawakami T, Isama K, Matsuoka A. 2011. Analysis of phthalic acid diesters, monoester, and other plasticizers in polyvinyl chloride household products in Japan. J Environ Sci Health A Tox Hazard Subst Environ Eng 46:855-864.
9. Koch HM, Bolt HM, Preuss R, Angerer J. 2005. New metabolites of di(2-3thylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 79:367-376.
10. Koch HM, Calafat AM. 2009. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 364:2063-2078.
11. Koch HM, Drexler H, Angerer J. 2003. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. Int J Hyg Environ Health 206:77-83.
12. Kohn MC, Parham F, Masten SA, Portier CJ, Shelby MD, Brock JW, et al. 2000. Human exposure estimates for phthalates [Letter]. Environ Health Perspect 108:A440-A442.
13. Li Z, Romanoff LC, Lewin MD, Porter EN, Trinidad DA, Needham LL, et al. 2010. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expo Sci Environ Epidemiol 20:526-535.
14. Lorber M, Angerer J, Koch HM. 2010. A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate. J Expo Sci Environ Epidemiol 20:38-53.
15. National Research Council. 2008. Phthalates and Cumulative Risk Assessment: The Task Ahead. Washington, DC: National Academies Press.
16. Preau JL, Wong LY, Silva MJ, Needham LL, Calafat AM. 2010. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect 118:1748-1754.
17. Schettler T. 2006. Human exposure to phthalates via consumer products. Int J Androl 29:134-139.
18. U.S. EPA (U.S. Environmental Protection Agency). 2012. Di(2-ethylhexyl)phthalate (DEHP) (CASRN 117-81-7). Available: http://www.epa.gov/iris/subst/0014.htm [accessed 24 August 2012].
19. Wittassek M, Wiesmüller GA, Koch HM, Eckard R, Dobler L, Müller J, et al. 2007. Internal phthalate exposure over the last two decades-a retrospective human biomonitoring study. Int J Hyg Environ Health 210:319-333.
20. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. 2006. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal 26(3):803-824.
21. Ye X, Wong L-Y, Bishop AM, Calafat AM. 2011. Variability of urinary concentrations of bisphenol a in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 119:983-988.